SCHEMBL7029698

SCHEMBL7029698

CC(C)COC1c2cccc(Cl)c2C(=O)c2cccc(Cl)c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
HTT P42858 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 2/20 0.33
ADORA2A P29274 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
POLB P06746 1/20 0.33
TRPA1 O75762 1/20 0.32
CYP1A1 P04798 1/20 0.31
CYP1A2 P05177 1/20 0.31
MEN1 O00255 1/20 0.30
TP53 P04637 1/20 0.30
NPY1R P25929 1/20 0.30
NPY2R P49146 1/20 0.30
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
SMARCA2 P51531 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7030240 0.83 ALDH1A1 (0.34) ALDH1A1MAPTADORA2ASMARCA2SMARCA4
SCHEMBL11481819 0.71 ADORA2A (0.39) ALDH1A1MAPTADORA2ATDP1MEN1
SCHEMBL20902858 0.70 HTR7 (0.43) ALDH1A1ADORA2ASMARCA2SMARCA4PBRM1
SCHEMBL16708761 0.67 ALDH1A1 (0.40) ALDH1A1MAPTPOLBMEN1TP53
SCHEMBL6904744 0.67 ADORA2A (0.41) ALDH1A1HTTSMN1; SMN2MAPTADORA2A
SCHEMBL9122030 0.64 ADORA2A (0.43) ALDH1A1SMN1; SMN2MAPTADORA2ACYP1A2
SCHEMBL7028632 0.63 PBRM1 (0.41) ALDH1A1SMN1; SMN2MAPTADORA2ARAB9A
SCHEMBL125609 0.62 NSD2 (0.55) ALDH1A1HTTSMN1; SMN2MAPTADORA2A
SCHEMBL8671883 0.61 ADORA2A (0.57) ALDH1A1HTTSMN1; SMN2MAPTADORA2A
SCHEMBL29401197 0.61 ADORA2A (0.57) ALDH1A1SMN1; SMN2MAPTADORA2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596774-B1 For their ability to inhibit the growth of human oral epidermoid carcinoma cells, human cervical carcinoma cells and Chinese hamster ovary cells NATIONAL SCIENCE COUNCIL OF R.O.C. (TW) 2003-07-22 US disclosed
US-20030135060-A1 Synthesis, lipid peroxidation and cytotoxic evaluation of 10-substituted 1,5-dichloro-9(10H)-anthracenone derivatives NATIONAL SCIENCE COUNCIL OF R.O.C. (TW) 2003-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030135060-A1 Synthesis, lipid peroxidation and cytotoxic evaluation of 10-substituted 1,5-dichloro-9(10H)-anthracenone derivatives GPX4, GPX1, AGK ALDH1A1 714/4885HTT 4862/4885SMN1; SMN2 4711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.